{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:46:12Z","timestamp":1792608372164,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T00:00:00Z","timestamp":1695254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.cmi.2023.09.015","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T02:21:54Z","timestamp":1695349314000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Guozhong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunli","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2023.09.015_bib1","series-title":"Global tuberculosis report","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.cmi.2023.09.015_bib2","series-title":"WHO consolidated guidelines on tuberculosis: module 4: treatment-drug-resistant tuberculosis treatment [Internet], 2022 update","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.cmi.2023.09.015_bib3","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(15)00458-0","article-title":"Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis","volume":"3","author":"Kendall","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2023.09.015_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/cid\/ciaa613","article-title":"Concordance of drug-resistance profiles between persons with drug-resistant tuberculosis and their household contacts: a systematic review and meta-analysis","volume":"73","author":"Chiang","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/pathogens11101189","article-title":"Preventive therapy for contacts of drug-resistant tuberculosis","volume":"11","author":"Kherabi","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.cmi.2023.09.015_bib6","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1164\/rccm.201909-1874ST","article-title":"Treatment of drug-resistant tuberculosis. An official ATS\/CDC\/ERS\/IDSA clinical practice guideline","volume":"200","author":"Nahid","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.09.015_bib7","series-title":"WHO consolidated guidelines on tuberculosis: tuberculosis preventive treatment: module 1: prevention [Internet]","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.cmi.2023.09.015_bib8","first-page":"56","article-title":"ECDC guidance on management of contacts of MDRTB and XDRTB patients","volume":"40","author":"Sandgren","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.09.015_bib9","series-title":"Tuberculosis. Practical guide for clinicians, nurses, laboratory technicians and medical auxiliaries","year":"2022"},{"key":"10.1016\/j.cmi.2023.09.015_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5588\/ijtld.11.0437","article-title":"Lack of evidence to support policy development for management of contacts of multidrug-resistant tuberculosis patients: two systematic reviews","volume":"16","author":"van der Werf","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib11","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/cid\/cix208","article-title":"Systematic Review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis","volume":"64","author":"Marks","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib12","series-title":"Latent TB infection: updated and consolidated guidelines for programmatic management [Internet]","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.cmi.2023.09.015_bib13","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.09.015_bib14","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1473-3099(20)30276-0","article-title":"Interferon-\u03b3 release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis","volume":"20","author":"Zhou","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.09.015_bib16","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2023.09.015_bib17","series-title":"Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. Updated October, Gradepro","year":"2013"},{"key":"10.1016\/j.cmi.2023.09.015_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/INF.0000000000000260","article-title":"Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis","volume":"33","author":"Adler-Shohet","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2023.09.015_bib19","doi-asserted-by":"crossref","first-page":"912","DOI":"10.5588\/ijtld.13.0028","article-title":"Treatment for LTBI in contacts of MDR-TB patients, Federated States OF Micronesia, 2009-2012","volume":"18","author":"Bamrah","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1183\/23120541.00149-2021","article-title":"Latent tuberculosis infection among contacts of patients with multidrug-resistant tuberculosis in New South Wales, Australia","volume":"7","author":"Chang","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.cmi.2023.09.015_bib21","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.5588\/ijtld.12.0092","article-title":"Long-term follow-up of contacts exposed to multidrug-resistant tuberculosis in Victoria, Australia, 1995-2010","volume":"16","author":"Denholm","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib22","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.5588\/ijtld.13.0872","article-title":"Children exposed to multidrug-resistant tuberculosis at a home-based day care centre: a contact investigation","volume":"18","author":"Garcia-Prats","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib23","doi-asserted-by":"crossref","first-page":"171","DOI":"10.5588\/ijtld.21.0443","article-title":"Fluoroquinolone preventive therapy for children exposed to MDR-TB","volume":"26","author":"Gureva","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1164\/ajrccm.153.1.8542139","article-title":"Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis","volume":"153","author":"Kritski","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.09.015_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3201\/eid2703.203916","article-title":"Effectiveness of Preventive therapy for persons exposed at home to drug-resistant tuberculosis, Karachi, Pakistan","volume":"27","author":"Malik","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib26","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1542\/peds.109.5.765","article-title":"Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up","volume":"109","author":"Schaaf","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.cmi.2023.09.015_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3201\/eid2103.141313","article-title":"Moxifloxacin prophylaxis against MDR TB, New York, New York, USA","volume":"21","author":"Trieu","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.cmi.2023.09.015_bib28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/INF.0b013e31829157e9","article-title":"Management of pediatric contacts of multidrug resistant tuberculosis in the United Kingdom","volume":"32","author":"Williams","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2023.09.015_bib29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1164\/rccm.201908-1576OC","article-title":"Isoniazid preventive therapy in contacts of multidrug-resistant tuberculosis","volume":"202","author":"Huang","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2023.09.015_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/thx.2008.100974","article-title":"Risk of tuberculosis in close contacts of patients with multidrug resistant tuberculosis: a nationwide cohort","volume":"64","author":"Attamna","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2023.09.015_bib31","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(20)30166-5","article-title":"Pediatric TB Contact Studies Consortium. The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis","volume":"21","author":"Martinez","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2023.09.015_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033945","article-title":"Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trial","volume":"10","author":"Fox","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2023.09.015_bib33","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1186\/s13063-018-3070-0","article-title":"Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)","volume":"19","author":"Seddon","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.cmi.2023.09.015_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02753-2021","article-title":"Global reporting on tuberculosis preventive treatment among contacts","volume":"59","author":"Falzon","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2023.09.015_bib35","first-page":"131","article-title":"Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis","volume":"167","author":"Papastavros","year":"2002","journal-title":"CMAJ"},{"key":"10.1016\/j.cmi.2023.09.015_bib36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199404283301718","article-title":"Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis","volume":"330","author":"Horn","year":"1994","journal-title":"N\u00a0Engl J Med"}],"updated-by":[{"DOI":"10.1016\/j.cmi.2024.03.024","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000}}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23004779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X23004779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T15:38:38Z","timestamp":1741275518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X23004779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1198743X23004779"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2023.09.015","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of tuberculosis preventive treatment for contacts of patients with multidrug-resistant tuberculosis: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2023.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}